These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18075138)

  • 1. The German MedTech industry in 2007.
    Schmitt JM; Beeres M
    Med Device Technol; 2007; 18(7):56. PubMed ID: 18075138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enthusiasm cools in Q2.
    Lawrence S
    Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
    [No Abstract]   [Full Text] [Related]  

  • 3. The industry in Europe: more together than apart.
    Med Device Technol; 2005 Nov; 16(9):32, 34, 36-7. PubMed ID: 16438447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on: Sweden.
    Biotechnol J; 2007 May; 2(5):528-30. PubMed ID: 17479974
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechnology round the world: focus on: Spain.
    Biotechnol J; 2008 Jan; 3(1):28-30. PubMed ID: 18200495
    [No Abstract]   [Full Text] [Related]  

  • 6. 2005: biotech partners up.
    Lawrence S
    Nat Biotechnol; 2006 Feb; 24(2):126. PubMed ID: 16465145
    [No Abstract]   [Full Text] [Related]  

  • 7. Tech transfer revs up.
    Lawrence S
    Nat Biotechnol; 2006 Jan; 24(1):13. PubMed ID: 16404380
    [No Abstract]   [Full Text] [Related]  

  • 8. The rise of the European bioentrepreneur.
    Alper J
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE3-5. PubMed ID: 12089569
    [No Abstract]   [Full Text] [Related]  

  • 9. VC funding hits high in Q1.
    Lawrence S
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract]   [Full Text] [Related]  

  • 10. 2006: a stellar year for financing.
    Lawrence S
    Nat Biotechnol; 2007 Feb; 25(2):156. PubMed ID: 17287738
    [No Abstract]   [Full Text] [Related]  

  • 11. Germany biotech gets second chance.
    Sheridan C
    Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract]   [Full Text] [Related]  

  • 12. The rise of European venture capital for biotechnology.
    Howell M; Trull M; Dibner MD
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract]   [Full Text] [Related]  

  • 13. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed results in Q1.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059
    [No Abstract]   [Full Text] [Related]  

  • 15. State of biotech sector--2005.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract]   [Full Text] [Related]  

  • 16. 2007--a banner year for biotech.
    Lawrence S
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolution of the biotechnology industry in Germany.
    Müller C
    Trends Biotechnol; 2002 Jul; 20(7):287-90. PubMed ID: 12062972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public biotechnology 2003-the numbers.
    Lähteenmäki R; Baker M
    Nat Biotechnol; 2004 Jun; 22(6):665-70. PubMed ID: 15175683
    [No Abstract]   [Full Text] [Related]  

  • 20. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.